4 ms·
Actually, no. The therapeutic index of chloroquine in the treatment of covid-19 is relatively high. Some people take chloroquine or hydroxychloroquine at about
by sudosysgen 7y ago
Actually, no.
The therapeutic index of chloroquine in the treatment of covid-19 is relatively high. Some people take chloroquine or hydroxychloroquine at about half the acute dosage used for covid-19 (autoimmune disorders) for literal years.
Given the half life as you mentioned, once or twice a week with enough lead time would be a sufficient dosage against covid-19 too. It's just that if you want to reach the concentration of chloroquine that you would have to take it over a long time otherwise, you need very high doses. And since you're already infected and have a ton of the virus, you also need higher concentrations than for prophylaxis.
- tim333 7y agoThe Chinese use 1g/day for treatment. A single dose of 3g can be fatal so not a massive margin. That said they've used it on hundreds of patients without adverse effects from the drug and probably a lot of lives saved from its effects on the virus.
- internet_user 7y agochloroquine is not frequently used for autoimmune. At doses used for corona, it is within 50% of margin, or even lower if you are a slow metabolizer of an LD50 dose. plaquenil on the other hand does have a higher therapeutic index. The other major disadvantage is that these drugs can interact with protease inhibitors.
- hackeerTwo 7y ago> The other major disadvantage is that these drugs can interact with protease inhibitors What are the possible consequences of this?
- internet_user 7y agoDeath. Kaletra, a protease inhibitor, is a combination of two drugs, one of which is a CYP3A4 inhibitor. It is used with some success on coronavirus patients. Co-administering this with chloroquine 500mg/BID could easily result in chloroquine concentrations well above LD50.